Page 57 - PCC07
P. 57

  i
e
in
n
P
Po
o
l
l
y
y
c
c
y
ys
s
t
ti
ic
c
O
Ov
va
ar
ry
y
S
Disclosure
Sy
y
n
nd
d
r
r
o
o
m
m
e
e
(
No conflicts of interest to declare
Funding obtained competitively with all funds to the employing institutions
Guideline contributors full disclosure of interest available at
https://www.monash.edu/medicine/sphpm/mchri
Search under MCHRI or ASK PCOS
  T
Th
hi
is
s
w
w
o
or
rk
ki
is
ss
s
u
up
p
p
p
o
o
r
r
t
t
e
ed
d
b
by
yt
th
h
e
eN
N
H
(
H
M
p
pr
MR
ro
oj
j
e
R
e
c
C
Cf
ct
tn
f
u
un
nu
u
m
nd
d
e
mb
e
d
b
e
d
C
er
Ce
rA
A
en
P
P
n
t
P
P
tr
re
1
1
e
f
0
fo
07
o
r
78
rR
84
Re
4
e
s
4
4
s
4
e
ea
4)
).
a
r
.
r
c
ch
hE
E
x
xc
ce
el
ll
le
e
n
n
c
c
e
  T
Th
i
e
in
hi
n
P
i
s
Po
ol
l
y
y
c
c
y
y
s
s
t
ti
ic
c
O
Ov
v
a
ar
r
y
y
S
S
y
y
n
nd
d
r
Learning objectives
ro
o
m
m
e
e(
 Increased knowledge of the internationally accepted Rotterdam criteria in PCOS
 Understanding of individual diagnostic criteria
 Understanding of diagnostic tests, risks and screening
recommendations
 Insight into what is new in the assessment and management of PCOS based on new international guidelines
 s
w
wo
o
r
r
k
ki
i
s
s
s
su
u
p
p
p
po
or
r
t
t
e
e
d
db
by
yt
t
h
h
e
e
N
N
H
(p
HM
pr
MR
ro
oj
j
e
R
e
c
C
Cf
c
t
tn
fu
un
nu
n
d
um
d
e
mb
e
d
be
dC
er
C
rA
A
e
e
n
P
P
n
t
P
t
P1
r
re
1
e
f
0
fo
07
or
7
r
R
8
84
Re
44
es
se
44
4
ea
)
).
ar
.
r
c
c
h
hE
Ex
x
c
ce
el
ll
l
e
en
n
c
c
e
 Page 50 of 196
  PRECONGRESS COURSE 07 I BARCELONA, SPAIN – 1 JULY 2018 57
  
   55   56   57   58   59